Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Airway hyperresponsiveness to inhaled mannitol identifies a cluster of non-eosinophilic asthma patients with high symptom burden

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Remission and changes in severity over 30 years in an adult asthma cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Potential Severe Asthma Hidden in UK Primary Care

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect

    Publikation: Bidrag til tidsskriftReviewpeer review

  5. The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Mast cell tryptase enhances wound healing by promoting migration in human bronchial epithelial cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Fractures and Osteoporosis in Patients With Diabetes With Charcot Foot

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Increased all-cause mortality in concomitant atopic dermatitis and asthma: A nationwide registry-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Patients with asthma are heterogeneous in clinical presentation and in response to treatment. Despite this, tools to guide treatment are limited and include mainly measures of eosinophilic inflammation and symptoms. Airway hyperresponsiveness (AHR) to mannitol is present in patients across inflammatory phenotypes and improve with inhaled corticosteroids.

OBJECTIVE: To investigate whether measuring AHR to mannitol in addition to eosinophilic inflammation and symptoms adds information to the phenotypic characterization of patients with asthma.

METHODS: A total of 317 patients with asthma from 6 different cohorts were included in the analysis. All patients had measures of AHR to mannitol, blood eosinophils, and Asthma Control Questionnaire 5 available. A cluster analysis using Ward minimum variance method was performed. The distribution of fraction of exhaled nitric oxide, immunoglobulin E, lung function, induced sputum inflammatory cell count, age of onset, and severity of disease was compared between clusters.

RESULTS: Four clusters were identified. Three of the clusters had proportionate levels of AHR, eosinophilic inflammation, and symptoms, but 1 cluster presented with low levels of eosinophilic inflammation and a significant symptom burden. Half of the subjects in this cluster presented with AHR to inhaled mannitol. Lung function, fraction of exhaled nitric oxide, body mass index, and immunoglobulin E were normal.

CONCLUSIONS: Information on AHR to mannitol in addition to blood eosinophils and symptoms identifies a subgroup of asthma patients with symptomatic, noneosinophilic disease. Airway hyperresponsiveness to mannitol may provide a treatable trait in a subgroup of patients with noneosinophilic asthma.

OriginalsprogEngelsk
TidsskriftThe journal of allergy and clinical immunology. In practice
ISSN2213-2198
DOI
StatusE-pub ahead of print - 28 jul. 2021

ID: 66949961